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ABSTRACT
Globally, ∼70% of adults are deficient in intestinal lactase, the
enzyme required for the digestion of lactose. In these individuals,
the consumption of lactose-containing milk and dairy products can
lead to the development of various gastrointestinal (GI) symptoms.
The primary solution to lactose intolerance is withdrawing lactose
from the diet either by eliminating dairy products altogether or
substituting lactose-free alternatives. However, studies have shown
that certain individuals erroneously attribute their GI symptoms
to lactose and thus prefer to consume lactose-free products. This
has raised the question whether consuming lactose-free products
reduces an individual’s ability to absorb dietary lactose and if
lactose-absorbers should thus avoid these products. This review
summarizes the current knowledge regarding the acclimatization of
lactose processing in humans. Human studies that have attempted
to induce intestinal lactase expression with different lactose feeding
protocols have consistently shown lack of enzyme induction.
Similarly, withdrawing lactose from the diet does not reduce
intestinal lactase expression. Evidence from cross-sectional studies
shows that milk or dairy consumption is a poor indicator of lactase
status, corroborating the results of intervention studies. However,
in lactase-deficient individuals, lactose feeding supports the growth
of lactose-digesting bacteria in the colon, which enhances colonic
lactose processing and possibly results in the reduction of intolerance
symptoms. This process is referred to as colonic adaptation. In
conclusion, endogenous lactase expression does not depend on the
presence of dietary lactose, but in susceptible individuals, dietary
lactose might improve intolerance symptoms via colonic adaptation.
For these individuals, lactose withdrawal results in the loss of
colonic adaptation, which might lower the threshold for intolerance
symptoms if lactose is reintroduced into the diet. Am J Clin Nutr
2019;110:273–279.
Keywords: lactose, lactase, lactase-phlorizin hydrolase, colonic
adaptation, lactose intolerance, dietitians, nutritionists
Introduction
In mammalian milk, the main carbohydrate and energy
source is lactose. Lactose is a disaccharide consisting of 2
monosaccharides, glucose and galactose, linked together via a β-
1→4 bond. Hydrolysis of this bond requires a specific enzyme
called lactase which digests lactose to its components allowing
the uptake of glucose and galactose from the intestine. In most
mammals, intestinal lactase activity is high at birth but starts
to progressively decline after weaning, eventually curtailing the
ability to digest dietary lactose (1, 2). However, in some humans,
a genetic trait enables intestinal lactase activity to persist into
adulthood. Globally, ∼30% of the world’s population are lactase
persistent as adults but the prevalence of lactase persistence
varies between populations and ethnicities (3). Traditionally,
cultures that have relied on pastoralism and dairy products
in the past exhibit higher prevalence of lactase persistence
than populations with little dairy consumption. For example, in
Southeast Asia >90% are lactase deficient as adults, whereas in
Scandinavia the prevalence of lactase deficiency is only ∼10%
(3). The now generally accepted culture-historical theory states
that the lactase-persistent phenotype emerged as a result of
positive selection due to a nutritional advantage conferred by the
continued ability to consume milk and dairy products (2–5).
Today, over 6 billion people regularly consume milk and dairy
products, and the per-capita consumption has nearly doubled in
developing countries since the 1960s (6). Nutritionally, milk and
dairy products are an important source of energy, proteins, fats,
and nutrients such as calcium and vitamin D (2). However, upon
consuming these products, some lactase-deficient individuals
may experience various gastrointestinal (GI) symptoms, such as
bloating, diarrhea, and abdominal pain, due to a condition called
lactose intolerance. The primary solution to lactose intolerance
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is to avoid lactose-containing dairy products altogether or to
replace themwith lactose-free alternatives (2). The dairy industry
has responded to this need by developing several lactose-free
products which are now readily available to consumers. In
addition, cultural changes, such as the increased popularity of
veganism and the globalization of the food industry, have also
led to the introduction of novel lactose- and dairy-free products.
Although an obvious need for these products exists, their
increased availability has perhaps fueled some misconceptions
about lactase deficiency and lactose intolerance. Firstly, lactase
deficiency itself does not indicate lactose intolerance; many
lactose-malabsorbers can tolerate certain amounts of dietary
lactose without any symptoms (7). Secondly, some individuals
who claim to be lactose intolerant fail to distinguish lactose
from placebo in controlled settings (8). These findings suggest
that certain people attribute their GI symptoms erroneously
to lactose and thus opt to consume lactose-free products.
This has subsequently raised the question whether consuming
lactose-free products reduces an individual’s ability to absorb
dietary lactose and if lactose-absorbers should thus avoid these
products.
The aim of this review was to evaluate the current evidence
regarding the acclimatization of lactose processing in humans.
An extensive literature search was undertaken of the PubMed
and Scopus databases for the terms “lactase/lactose adaptation,”
and the reference lists of relevant review articles were also
examined. This review included human studies measuring
lactose absorption after periods of lactose or lactose-free diet
consumption.
Mechanisms of Lactose Absorption
Lactase-phlorizin hydrolase (LPH), or simply lactase, belongs
to a group of intestinal disaccharidases located on the brush
border of the small intestine. Spatially, the abundance of
LPH is highest in the proximal part of the jejunum and
progressively declines towards the ileum (1, 2). LPH contains 2
distinct enzymatically active sites: the β-galactosidase site (EC
3.2.1.23) and the glycosylceramidase site (EC 3.2.1.62). The β-
galactosidase site forms the lactase domain which hydrolyzes
lactose to glucose and galactose, whereas the phlorizin hydrolase
activity located on the glycosylceramidase site cleaves phlorizin
and several dietary glycolipids (2, 5). Despite the presence of this
latter activity, lactose is the most significant nutritional substrate
of LPH.
The expression of intestinal lactase is under developmental
regulation. In humans, intestinal lactase activity starts to increase
during the third trimester, eventually reaching its peak at birth (1).
Healthy infants usually exhibit high lactase activity, but the post-
weaning period sees the emergence of 2 phenotypes: lactase de-
ficiency and lactase persistence. In lactase-deficient individuals,
lactase expression begins to gradually decrease some time during
childhood, eventually making them incapable of digesting dietary
lactose. This condition is referred to as adult-type hypolactasia.
The age of onset for hypolactasia varies considerably between
individuals and populations with some children exhibiting low
lactase concentrations at as young as 2 y of age (9). In contrast
to lactase deficiency, lactase-persistent individuals continue to
express high lactase activity after childhood (i.e., normolactasia)
and retain the ability to digest lactose. Generally, the cut-off value
for hypolactasia is ∼10–15 U/g of total protein whereas lactase-
persistent individuals exhibit lactase activities >50 U/g of total
protein.
The phenotypic differences between adult-type hypolactasia
and normolactasia are explained by genetic polymorphism. In
people with European ancestry, hypolactasia associates with 2
distinct allelic variants upstream of the lactase gene (LCT), C/T-
13910 and G/A-22018 (10). Of these two variants, the C/T-13910
polymorphism residing on the enhancer region of LCT is the main
regulator of lactase expression; the G/A-22018 polymorphism
does not seem to affect lactase expression (11). The CC genotype
implies reduced lactase activity, whereas the TT genotype is
associated with normolactasia. Heterozygotes with the C/T
genotype are usually lactase persistent but display lower lactase
activities than TT homozygotes, although considerable overlap
in lactase activities between these 2 genotypes exists (12, 13).
Also, individuals with the CC genotype show varying lactase
activities, suggesting that some lactase-deficient individuals
might be better at digesting lactose than others (12). In addition
to the C/T-13910 variant, ≥4 other allelic variants on the
LCT enhancer region associate with lactase persistence in
different ethnic populations: allelic variants C/G-13907, G/T-
14009, and G/C-14010 are present at varying frequencies in
East Africa, whereas the T/G-13915 variant is mainly found
on the Arabian Peninsula (14). Despite the relatively well-
characterized genetics of lactase deficiency, the exact molec-
ular mechanisms behind the genetically programmed decline
in lactase expression remain only partially understood. Re-
cently, 2 independent research groups demonstrated C/T-13910
genotype-dependent differences in DNA methylation patterns
that associate with LCT mRNA expression and lactase activity,
indicating that intestinal lactase is mainly under transcriptional
regulation (15, 16).
In addition to endogenous lactase activity, certain colonic
microbes, such as the lactic acid bacteria Lactobacillus and
Bifidobacterium, possess β-galactosidase activity (i.e., bacterial
lactase) that allows them to digest and utilize lactose. These
bacteria hydrolyze lactose to glucose and galactose and sub-
sequently ferment them to lactate, SCFAs, and gases, such
as H2, CO2, and CH4 (17). In normolactasia, when intestinal
lactase is high, only a small percentage of ingested lactose
reaches the colon (18). However, when intestinal lactase activity
is low, lactose escapes absorption in the small intestine, thus
subjecting it to colonic fermentation. The colonic fermentation
process might explain why certain lactase-deficient individuals
experience intolerance symptoms to lactose whereas others do
not (17). Although lactose-tolerant and lactose-intolerant lactose-
malabsorbers exhibit similar fecal β-galactosidase activity (i.e.,
capacity to hydrolyze lactose) (19), the fecal bacteria of
the intolerant subjects generate fermentation end products in
response to lactose faster than those of the tolerant group
(20). Together with undigested lactose, the rapid accumulation
of fermentation products increases the osmotic load in the
colonic lumen, leading to intolerance symptoms after lactose
intake (17).
Researchers and clinicians have employed several methods
to assess an individual’s ability to absorb dietary lactose (21).
Clinically, these methods are important because they can be used
to exclude lactose intolerance when diagnosing functional GI
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disorders. Intestinal lactase activity can be measured directly
from intestinal biopsies or indirectly with a lactose challenge.
Although direct measurement is the reference standard, obtaining
biopsies is invasive and rarely available, making indirect
measurements more practical for routine assessments. The 2
most frequently used indirect measurements of lactase status are
the lactose tolerance test (LTT) and the H2-breath test (21). In
both tests, a subject is challenged with an oral dose of 20–50
g lactose after which blood glucose concentrations (LTT) or H2
concentrations in expiratory air are measured for every 30min for
2–3 h. The LTT is based on intestinal lactase’s ability to hydrolyze
lactose to galactose and glucose: blood glucose concentrations
failing to increase 20 mg/dL above pretest values are indicative
of lactase deficiency. In contrast, the H2-breath test is based
on the activity of colonic microbes: when lactase activity is
low, unabsorbed lactose enters the colon where colonic microbes
produce H2 via a fermentation process. If breath H2 concentration
rises 20 ppm above pretest values, it is regarded as a sign of
reduced lactase activity. Both the LTT and the H2-breath test
are susceptible to confounding factors but the major advantage
of these tests is that they allow symptom assessment during
testing so they can also be used to diagnose lactose intolerance
(21). In addition to these tests, a genetic test for the C/T-13910
polymorphism is available with the CC genotype interpreted as
lactase deficiency. Although this polymorphism correlates well
with lactase activity, it mainly reflects lactase status in European
populations in which lactase persistence mostly depends only
on the C/T-13910 variant (14). Because different allelic vari-
ants determine lactase persistence in other ethnicities, genetic
testing for the C/T-13910 polymorphism is unsuitable for these
populations (21).
Does Lactose Absorption Acclimatize to Lactose
Intake in Humans?
The first experiments on the induction of intestinal lactase
in response to dietary lactose intake were conducted as long
ago as the beginning of the 20th century when researchers fed
different animal species milk or lactose and analyzed changes
in their lactase activity. Although these experiments relied on
cruder analytic methods than today, they showed that lactose
feeding does not induce intestinal lactase activity in adult
mammals (22). Subsequent animal studies with modern methods
of analysis have produced conflicting findings, with some
studies showing increased intestinal lactase activities following
lactose feeding (23–28), whereas others have reported no such
effect (29–33).
In humans, studies attempting to induce intestinal lactase with
different lactose feeding protocols have consistently produced
negative findings (Table 1). Cuatrecasas et al. (34) were the
first to examine the induction of intestinal lactase in humans
by feeding 150 g of lactose daily to 11 subjects (7 lactose-
malabsorbers and 4 lactose-absorbers) for 45 d and reported
no changes in intestinal lactase activity. Similarly, in by far the
largest study in terms of subjects, Keusch et al. (35) reported no
changes in intestinal lactase activity in 50 Thai marines following
a lactose-feeding period of 22–38 d. Smaller studies and case
reports with various lactose-feeding protocols have reported
similar findings (36–42). In the only intervention study conducted
exclusively in children, feeding 25 g of lactose daily for 1 y did
not improve lactose absorption in lactose-malabsorbing children
(43). Additionally, lactose feeding did not seem to prevent the
decline in lactose-absorbing capacity because 5 of 8 previously
lactose-absorbing children became lactose-malabsorbers during
the intervention. The 3 children who remained lactose-absorbers
were all aged <5 y, suggesting that age, and not lactose intake,
was the major factor affecting the status of lactose absorption in
this population (43).
Intervention studies where lactose is eliminated from diet are
scarce and have produced somewhat conflicting results (Table 1).
Cuatrecasas et al. (34) put 2 lactose-absorbers on a lactose-
free diet and observed a decline in their lactose absorption
capacity. In 1 of the subjects, the lactose absorption capacity
fell almost to half of the baseline value after only 2 mo but
did not decline further. In this study lactose absorption capacity
was measured as lactose absorption ratio, whereby the rise in
blood glucose concentration after lactose intake is expressed as a
percentage of the rise in blood glucose after ingesting a solution
containing an equal amount of glucose and galactose (34). The
authors established a cut-off value of 50% for lactose absorption.
Notably, although both subjects exhibited decreased lactose
absorption capacity after the intervention period, both would still
be classified as lactose-absorbers according to the established cut-
off value (34). In another study, removing lactose from the diet
of 6 healthy lactose-absorbers for 42 d produced varying results:
intestinal lactase activity increased in 2 subjects and decreased
in 3 (44). However, these changes did not affect the results
of the LTT, leading the authors to speculate that the observed
fluctuations in lactase activity likely resulted from variations in
the location of the biopsy specimen (44). This is a reasonable
assumption considering the spatial differences in intestinal
lactase expression and that other intestinal disaccharidases
followed a similar pattern in their analyses. Furthermore, all
subjects whose intestinal lactase activity decreased during the
study still exhibited sufficient lactase activity and experienced no
GI symptoms during the LTT, indicating that lactose withdrawal
did not affect their ability to process dietary lactose (44). Taken
together, the results from intervention studies show that intestinal
lactase activity is not modified by the presence of lactose in the
diet.
Cross-sectional studies offer another way to investigate the
possible relation between lactose absorption and lactose intake.
Obviously, this type of study cannot establish causality, i.e.,
whether lactose intake affects lactose absorption capacity or if
poor lactose absorption causes avoidance of lactose-containing
products. On a global level, populations with a high prevalence
of lactase deficiency consume less lactose-containing dairy
products than populations where lactase persistence dominates
(3, 45). This most likely echoes the culture-historical theory
of population-level adaptation, gradually leading to a high
prevalence of lactase persistence in cultures where dairy
products are commonly available for nutrition. However, on
an individual level, milk or lactose consumption appears to
be a poor indicator of a person’s lactose absorption status.
Lactose absorption capacity (enzyme activity or LTT) shows no
correlation with daily milk intake in several populations (36, 46–
50). Also, studies have identified multiple individuals incapable
of absorbing lactose despite regular daily milk consumption (48,
51–54) or lactose-absorbing individuals who have consumed
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TABLE 1 Intervention studies investigating changes in intestinal lactase activity in humans after a lactose feeding period or a period of lactose withdrawal1
Study population n Age Intervention Result Reference
Lactose-malabsorbers 7 Adults 150 g lactose/d for 45 d No change in intestinal lactase activity (34)
Lactose-absorbers 4 Adults 150 g lactose/d for 45 d No change in intestinal lactase activity (34)
Lactose-absorbers 2 Adults Abstinence from milk and milk
products for 5 mo
Lactose absorption ratio decreased in
both subjects
(34)
Healthy Caucasian lactose-absorbers 2 Adults 50 g of lactose 3 times/d for 10 d No change in intestinal lactase activity (36)
Healthy Caucasian lactase-deficient
subjects
1 Adult Diet with 30% of calories from
lactose for 14 d
No change in intestinal lactase activity (37)
Healthy Caucasian lactose-absorbers 6 — Lactose-free diet for 42 d Varying results in intestinal lactase
activity, no change in LTT
(44)
Healthy Thai marines 50 22–30 y 25 g of lactose 2 times/d for
22–38 d
No change in intestinal lactase activity (35)
Lactose-intolerant Nigerian medical
students
6 Adults Gradual weekly increase of
lactose intake from 5 to 100 g/d
for 6 mo
No improvement in LTT (42)
Japanese nursing students 14 18–20 y 360–540 mL milk/d for 52 d No improvement in LTT (38)
Healthy Indians 6 Adults 30 g of lactose for 4 wk No change in intestinal lactase activity (39)
Lactase-deficient subjects 10 21–65 y 0.7–1.4 L milk/d for 6–14 mo No change in intestinal lactase activity (40)
Lactose-malabsorbing children from
a Singaporean girls’ home
13 5–10 y 25 g lactose/d for 1 y All but 1 child remained
lactose-malabsorbers (per LTT)
(43)
Lactose-absorbing children from a
Singaporean girls’ home
8 3–7 y 25 g lactose/d for 1 y Only 3 children (all aged <5 y)
remained lactose-absorbers (per LTT)
(43)
Healthy lactose-malabsorbing
Cameroonians
16 18–26 y 18 g lactose/d for 7 d No change in intestinal lactase activity (41)
1LTT, lactose tolerance test.
no or little milk products after weaning (46, 48, 55–57). For
example, in a 10-y follow up study, Sahi et al. (52, 55)
reported the development of hypolactasia in people who had
regularly drunk milk for several years. In their study cohort,
all previously identified lactose-malabsorbers also remained as
such during the 10-y follow-up period even though some of them
continued consuming milk regularly. One notable exception to
the aforementioned studies is a report from Bolin and Davis
(58) describing a lower incidence of lactose malabsorption
in Australian-born Chinese than indigenous Chinese living in
Singapore. In their study population, all lactose-absorbers also
reported consuming >15 g lactose/d, whereas most lactose-
malabsorbers reported lower lactose consumption (58). Never-
theless, the overall evidence from cross-sectional studies seems
to support the findings of the intervention studies that lactose
absorption capacity does not depend on the availability of dietary
lactose.
Considering that the age of onset for lactase deficiency varies
considerably between populations, studies examining the relation
betweenmilk consumption habits and intestinal lactase activity in
young children are especially interesting. Cook (59) reported that
Ugandan children exhibited a gradual fall in lactose absorption
capacity from birth to childhood irrespective of their milk
intake. Similarly, in a study conducted in Thailand, continuous
milk intake since infancy did not prevent a decline in lactose-
absorbing capacity (60). Furthermore, studies on Peruvian and
Israeli children reported that the lactose-absorbing capacity in
these populations was not related to milk consumption during
childhood (61, 62). On the other hand, others have suggested
that although lactase status is genetically determined, continued
lactose intake after weaning could increase the age of onset
for hypolactasia (51, 63). This is mostly supported by data
showing that in populations where milk consumption is high,
hypolactasia appears at a later age than in populations with
low milk consumption (39, 51, 54, 59, 60, 62–66). In a study
cohort consisting of Mexican-American children and Anglo-
American children, lactose malabsorption manifested earlier in
the Mexican-American group who also consumed less milk
than the Anglo-American children (64). Bolin et al. (65) also
observed an increased prevalence of hypolactasia in non-milk-
drinking children aged <5 y than in milk-drinking children of
similar age. However, the causality of this relation is uncertain.
In the only intervention study conducted in young children,
milk supplementation for 1 y did not prevent or delay the
development of hypolactasia (43). This study was conducted in
a Singaporean population where the prevalence of hypolactasia
is high. Possibly, the observed variations in the age of onset
for hypolactasia in different populations are under generic or
epigenetic regulation and lactose intake does not influence this
process.
Colonic Adaptation to Dietary Lactose
Although endogenous lactase activities remain unchanged
during lactose feeding, lactose-malabsorbers frequently report
experiencing fewer and less severe GI symptoms as feeding
progresses. This would suggest that some adaptive mechanisms
relating to lactose processing occur during prolonged intake of
lactose. In one of the first studies to demonstrate adaptation
to lactose feeding, Johnson et al. (67) fed gradually increasing
amounts of lactose to 22 lactose-intolerant subjects and observed
that 17 of them could tolerate >12 g of lactose daily without
symptoms. In addition, when challenged with the maximum
tolerated dose of lactose, 4 of these subjects exhibited no increase
in breath H2 concentration (67). Subsequent investigations
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TABLE 2 Intervention studies investigating colonic adaptation in humans after a lactose-feeding period
Study population n Age Intervention Result Reference
Lactose-malabsorbing
African Americans
22 13–39 y Gradually increased daily lactose intake for
6–12 wk until tolerated dose was reached
Breath H2 concentration <5 ppm in 4 of
22 subjects
(67)
Lactose-malabsorbing
subjects
9 30 y
(mean)
Gradually increased daily lactose intake for 16
d from 0.2 to 1.0 g lactose/kg body weight
Increase in fecal β-galactosidase activity (68)
Lactose-malabsorbing
subjects
20 30 y
(mean)
Gradually increased daily lactose intake for 10
d from 0.6 g to 1.0 g lactose/kg body weight
Decrease in breath H2 concentrations (68)
Lactose-malabsorbing
subjects
24 20–47 y 17 g lactose 2 times/d for 14 d Increased fecal β-galactosidase activity
and decreased breath H2
concentrations
(69)
Lactose-malabsorbing
African-Americans girls
14 11–15 y 33 g lactose/ d for 21 d Decrease in breath H2 concentrations (70)
Healthy Sicilian man 1 32 y Decreased daily lactose intake from 28.1 to 1.5
g for 2–3 wk and then increased daily
lactose intake to 53 g
Increase in breath H2 concentration
followed by a decrease after
reintroducing high daily lactose
intake
(71)
Lactase-deficient subjects 23 32 ± 9 y 25 g lactose 2 times/d for 14 d Increased fecal Bifidobacteria counts (73)
Lactase-persistent subjects 18 26 ± 7 y 25 g lactose 2 times/d for 14 d No changes in fecal bacterial counts (73)
have produced similar findings: lactose-malabsorbing individuals
show decreased breathH2 concentrations after a lactose challenge
following a lactose-feeding period (68–71) (Table 2). Although
these reports have reported none or only minor improvements
in GI symptoms, the findings imply that colonic microbes adapt
to the presence of lactose in the colonic lumen. Indeed, fecal
analyses have revealed that lactose feeding increases fecal β-
galactosidase activity (68, 69) and the proportions of Lactobacilli
and Bifidobacteria (72, 73). Interestingly, these bacterial taxa do
not produce H2 during carbohydrate fermentation, which likely
explains the observed reduction in breath H2 concentrations
after lactose feeding (74). These results suggest that when
dietary lactose reaches the colon, it stimulates the growth of
lactose-fermenting bacteria, but whether this reduces intolerance
symptoms to lactose is still a matter of debate. Studies
have shown decreased flatulence during a lactose challenge
following a lactose-feeding period, possibly because of microbial
changes leading to reduced colonic gas production (68, 70).
Colonic adaptation is also supported by a study showing that
supplementing lactose-intolerant individuals with a prebiotic
increases the proportion of lactose-fermenting bacteria, which
leads to decreased abdominal pain when lactose is reintroduced
in the diet (75, 76). Taken together, however, these studies mainly
report only minor improvements in 1 intolerance symptom with
no changes in other GI symptoms (68, 70, 75). Moreover, Briet
et al. (69) did not observe any improvements in intolerance
symptoms despite microbial adaptations to lactose intake,
supporting the idea that at least part of the observed symptom
improvements could be explained by the placebo effect. Another
explanation could be individual differences in the composition
of microbiota that contribute to GI symptom development after
lactose intake. Although fecal β-galactosidase activity does not
seem to differ between lactose-tolerant and lactose-intolerant
lactose-malabsorbers (19), intolerant individuals produce lactose
fermentation end products, such as lactate and SCFAs, faster
than tolerant lactose-malabsorbers (20). These findings imply
that colonic adaptation to lactose intake should probably extend
beyond β-galactosidase–producing bacteria to achieve clear
alleviation of intolerance symptoms. Nevertheless, these studies
show that lactose feeding increases the proportion of intestinal
bacteria capable of hydrolyzing lactose and decreases colonic
H2 production, trends that might lead to some alleviation of
intolerance symptoms in lactose-malabsorbers. This colonic
adaptation to lactose feeding appears to be reversible, i.e.,
when lactose is excluded from diet, colonic adaptation also
disappears, which in turn might lead to intolerance symptoms
when lactose is reintroduced in the diet. However, despite colonic
adaptation, the nutritional benefit of lactose for these individ-
uals would still remain low compared with lactase-persistent
individuals.
Conclusions and Future Research Targets
Studies that have measured changes in endogenous lactase
activity after an intervention period consistently show a lack of
enzyme induction, suggesting that lactose intake does not affect
an individual’s lactase activity. Although these studies are scarce
and have relatively few subjects, data from cross-sectional studies
support the theory of purely genetic regulation. However, a few
questions remain open. Firstly, the existing intervention studies
have mainly been conducted on subjects from populations with
a high prevalence of hypolactasia. This implies that most of the
subjects in these studies are genetically homozygous for lactase
deficiency, meaning that their ability to express lactase might
have already been compromised permanently. Perhaps extending
these analyses to include genetic polymorphisms with varying
lactase activities would produce a wider range of outcomes.
Secondly, considering that the age of onset for hypolactasia varies
extensively between populations, it would certainly be of interest
to investigate the genetic or epigenetic factors that trigger the
downregulation of lactase expression at a certain age in different
populations.
Contrary to endogenous lactase, the capacity of colonic
microbes to process lactose can adapt to increased flux of
lactose into the colonic lumen. Colonic adaptation occurs
mainly in lactase-deficient individuals and is possibly responsible
for the increased tolerance to lactose after a lactose-feeding
period, but this matter is still being debated and requires more
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detailed investigations. Nevertheless, in lactose-malabsorbing
individuals, withdrawing lactose from the diet might lead to
the loss of adaptation and subsequently lower the threshold
for intolerance symptoms when lactose is reintroduced. Over-
all, however, it remains unclear if lactose intake leads to
colonic adaptation in all lactose-malabsorbers and what are
the possible differences between adapters and nonadapters.
In addition, the microbial alterations contributing to colonic
adaptation after lactose feeding should be investigated more
thoroughly.
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